Table 9 Incidence of sequelae in each risk group
Major sequelae | Low risk (n = 24) | Intermediate risk (n = 52) | High risk* (n = 26) |
|---|---|---|---|
Recurrent UTI | 2 (8%) | 10 (19%) | 8 (31%) |
Obstructive voiding symptoms | 1 (4%) | 12 (23%) | 15 (58%) |
Persistent hydronephrosis | 2 (8%) | 18 (34%) | 18 (69%) |
Persistent VUR | – | 12 (4%) | 14 (54%) |
Progressive renal scarring | – | 9 (17%) | 12 (46%) |
Progressive uremia | – | 1 (2%) | 12 (46%) |
Valve bladder syndrome | – | 9 (17%) | 18 (69%) |
Systemic problems** | – | 1 (2%) | 14 (54%) |